Full central neurokinin-1 receptor blockade is required for efficacy in depression: evidence from orvepitant clinical studies
暂无分享，去创建一个
M. Fava | E. Rabiner | P. Bettica | R. Gomeni | H. Millns | S. Zamuner | Graeme Archer | D. Trist | E. Ratti | G. Evoniuk | R. Alexander | D. Carpenter | Mike Trower | Erica J. Lawson | Monica C. Lopez | R. Krishnan